TTT — TruTrace Technologies Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2018 March 31st | 2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.01 | 0.403 | 0.163 | 0.118 |
Cost of Revenue | |||||
Gross Profit | — | -0.055 | 0.398 | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.35 | 14.8 | 4.94 | 1.76 | 1.79 |
Operating Profit | -0.35 | -14.7 | -4.54 | -1.6 | -1.67 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.346 | -14.8 | -4.64 | -1.62 | -2.33 |
Net Income After Taxes | -0.346 | -14.8 | -4.64 | -1.62 | -2.33 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.346 | -14.8 | -4.64 | -1.62 | -2.33 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.346 | -14.8 | -4.64 | -1.62 | -2.33 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.094 | -0.157 | -0.055 | -0.014 | -0.014 |